Advertisement

Topics

Search Results for "Avesthagen Limited Cosmosid"

23:58 EST 9th December 2016 | BioPortfolio

Matching Channels

PATHSEEK

Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

RPL554

Verona’s lead drug, RPL554, is a dual phosphodiesterase (PDE) 3 and 4 inhibitor being developed as a novel treatment for chronic obstructive airways disease as COPD (chronic obstructive pulmon...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Coronavirus

Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...

Matching News

Qiagen and CosmosID launch metagenomics analysis plugin

The plugin for the Qiagen Microbial Genomics Pro Suite and CLC Genomics Workbench expands the firm's platform for NGS bioinformatics. Manoj Dadlani, CEO of CosmosID, said: " They start with raw se...

QIAGEN and CosmosID Launch New Plugin for Metagenomics Analysis

Bioinformatics expansion strengthens QIAGEN's Sample to Insight metagenomics solutions QIAGEN and CosmosID, a leading genomic big data company, today announced the launch of a metagenomics analysi...

Avesthagen Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...

QIAGEN, CosmosID launch new plugin for metagenomics analysis

QIAGEN and CosmosID have launched new metagenomics analysis plugin for the QIAGEN Microbial Genomics Pro Suite and CLC Genomics Workbench.

CosmosID Inc bioinformatics, cancer news

CosmosID Announces Oncobiome Partnership with the White House Cancer Moonshot Initiative

ROCKVILLE, Md., Oct. 17, 2016 /PRNewswire/ -- Today CosmosID announced participation in Vice President Biden's National Cancer Moonshot, which aims to accelerate progress in preventing, diagnosin...

Global Microbiome Initiative Explores Subways for Drug-Resistance Markers

Weill Cornell Medicine researchers will use tools and technologies from Qiagen and CosmosID in a global study that the partners said today will collect DNA and RNA samples from high-traffic areas in...

CosmosID and The BioCollective Offer a Whole Genome Shotgun Sequencing Based Comprehensive Microbiome Analysis Kit

ROCKVILLE, Md., June 17, 2016 /PRNewswire/ -- CosmosID and The BioCollective today announced a new Comprehensive Microbiome Analysis Kit for in-depth, high-resolution identification and characterizati...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement